Accelus Stock

Accelus is an minimally invasive spine surgery through its procedure-enabling technology.

Sign up today and learn more about Accelus Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Accelus Stock

Accelus is committed to accelerating minimally invasive spine surgery through its procedure-enabling technology with broad accessibility to previously underserved markets.


Chief Executive Officer & Co-Founder

Christopher Walsh

Chief Strategy Officer (CSO)

Andrew Wolf

Director of Clinical Research

Rachelle Yusufbekov

Chief Robotics Officer

Kevin T. Foley

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: